XBIO
Price:
$3.2
Market Cap:
$6.04M
Xenetic Biosciences, Inc. operates as a biopharmaceutical firm, primarily concentrating on the development of XCART. This cutting-edge personalized chimeric antigen receptor T cell (CAR T) platform is specifically engineered to identify and attack distinct tumor neoantigens found in individual patients. Beyond this specialized area, the company actively engages in the discovery, investigation, and creation of advanced biologic medicines and cancer treatments. A significant part of its cell-based therapeutic endeavors involves therapies designed to target the B-cell receptor on the exterior of malignant tumor cells in specific patients, with the aim of addressing B-cell lymphomas. Furthermore...[Read more]
Industry
Biotechnology
IPO Date
2016-06-30
Stock Exchange
NASDAQ
Ticker
XBIO
According to Xenetic Biosciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 7.93. This represents a change of 18.63% compared to the average of 6.68 of the last 4 quarters.
The mean historical Current Ratio of Xenetic Biosciences, Inc. over the last ten years is 8.27. The current 7.93 Current Ratio has changed 9.48% with respect to the historical average. Over the past ten years (40 quarters), XBIO's Current Ratio was at its highest in in the September 2021 quarter at 18.35. The Current Ratio was at its lowest in in the June 2016 quarter at 0.13.
Average
8.27
Median
8.08
Minimum
0.75
Maximum
13.20
Discovering the peaks and valleys of Xenetic Biosciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 950.02%
Maximum Annual Current Ratio = 13.20
Minimum Annual Increase = -75.35%
Minimum Annual Current Ratio = 0.75
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 8.32 | 12.89% |
| 2024 | 7.37 | -37.79% |
| 2023 | 11.84 | -6.92% |
| 2022 | 12.72 | -3.44% |
| 2021 | 13.18 | -0.20% |
| 2020 | 13.20 | 68.47% |
| 2019 | 7.84 | 950.02% |
| 2018 | 0.75 | -75.35% |
| 2017 | 3.03 | -32.25% |
| 2016 | 4.47 | 682.98% |
The current Current Ratio of Xenetic Biosciences, Inc. (XBIO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
9.17
5-year avg
10.68
10-year avg
8.27
Xenetic Biosciences, Inc.’s Current Ratio is less than Titan Pharmaceuticals, Inc. (301.55), greater than Ensysce Biosciences, Inc. (0.71), greater than Soligenix, Inc. (1.81), less than Oragenics, Inc. (133.42), less than Qualigen Therapeutics, Inc. (11.57), greater than Clearmind Medicine Inc. (3.79), greater than Kazia Therapeutics Limited (2.87), greater than KALA BIO, Inc. (7.91), greater than Can-Fite BioPharma Ltd. (3.46), greater than Abpro Corporation (0.74),
| Company | Current Ratio | Market cap |
|---|---|---|
| 301.55 | $3.11M | |
| 0.71 | $2.33M | |
| 1.81 | $4.43M | |
| 133.42 | $2.81M | |
| 11.57 | $5.43M | |
| 3.79 | $3.40M | |
| 2.87 | $23.13M | |
| 7.91 | $57.68M | |
| 3.46 | $1.53M | |
| 0.74 | $1.06M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Xenetic Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Xenetic Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Xenetic Biosciences, Inc.'s Current Ratio?
How is the Current Ratio calculated for Xenetic Biosciences, Inc. (XBIO)?
What is the highest Current Ratio for Xenetic Biosciences, Inc. (XBIO)?
What is the 3-year average Current Ratio for Xenetic Biosciences, Inc. (XBIO)?
What is the 5-year average Current Ratio for Xenetic Biosciences, Inc. (XBIO)?
How does the current Current Ratio for Xenetic Biosciences, Inc. (XBIO) compare to its historical average?